Építés alatt – nem éles oldal
Belépés

What researchers published on Prosztatarák

83 068 papers, newest first.

Showing 60 of 83 068

  • Quality-of-life outcomes of MR-guided ultrahypofractionated SBRT versus CBCT-guided moderately hypofractionated IMRT for localized prostate cancer: an EPIC-based real-world comparative study.Japanese journal of clinical oncology
  • Serotonin biosynthesis emerges as a metabolic driver in prostate cancer therapy resistance.The Journal of clinical investigation
  • Biopsy-to-radical Prostatectomy ISUP Grade Discordance and Prostate Cancer-Specific Mortality: A Population-based SEER Study.Annals of surgical oncology
  • Periprostatic Adipose Tissue Promotes Prostate Cancer Progression through Androgen Receptor-Mediated Lipolysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • The Inhibition of Biotransformation Enzymes Affects the Response of PC3 Prostate Cancer Cell Line to Docetaxel.Turkish journal of pharmaceutical sciences
  • Evaluating Artificial Intelligence Chatbots for Patient Education on Prostate Biopsy in the Prostate Cancer Diagnostic Pathway.Journal of cancer education : the official journal of the American Association for Cancer Education
  • Association between puberty timing and overall survival in male cancer patients: a prospective cohort analysis from the UK Biobank.BMC cancer
  • ÁttekintésTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • FTO/ZNF334 suppresses prostate cancer enzalutamide resistance through androgen receptor ubiquitination.Molecular and cellular endocrinology
  • Dual-tracer 68Ga-PSMA and 68Ga-FAPI PET/CT characterization of solitary testicular metastasis from castration-resistant prostate cancer.EJNMMI reports
  • Comparison of five definitions of meaningful change on patient-reported outcomes in four SWOG clinical trials.Journal of patient-reported outcomes
  • Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer.Oncogenesis
  • Targeting FOXA1 with repurposed tigecycline to overcome therapeutic resistance in castration-resistant prostate cancer.Journal of translational medicine
  • Burden of Prostate Cancer in the United States of America (USA): 1990-2023, Global Burden of Disease (GBD) Study 2023.The Prostate
  • MetaanalízisPrognostic value of ctDNA in patients with prostate cancer: a meta-analysis and trial sequential analysis.BMC cancer
  • Comparison of whole genome sequencing with clinical targeted panel sequencing of metastatic prostate cancer: insights from real-world data.NPJ precision oncology
  • Integration of individual-level social determinants of health and associations with cardiovascular risk factors in breast and prostate cancer.Cancer
  • ÁttekintésFrom Radical Treatment to Structured Active Surveillance: A Narrative Review of Low-Risk Localized Prostate Cancer.Journal of clinical medicine
  • EsetismertetésProstatic solitary fibrous tumor masquerading as prostate cancer on multiparametric MRI: A case report.Urology case reports
  • ÁttekintésLate Vertebral Metastasis in Long-Term Survivors of Breast, Prostate, and Renal Cell Cancer.Cancers
  • Preoperative prediction of complications after robot-assisted radical prostatectomy: development and internal validation of a prediction model compared with generic risk scores.World journal of urology
  • Contrast-Enhanced Ultrasound Combined with the NLR-PMR Phenotype for Prostate Cancer Prediction and Risk Stratification in Patients with PSA 4-20 ng/mL and PI-RADS ≤ 3.Diagnostics (Basel, Switzerland)
  • Chromatin compartment shifting is recurrent and associated with epigenetic reprogramming in prostate cancer.iScience
  • Electrospun Poly(lactide-co-glycolide-co-ε-caprolactone) as a Bioresorbable Platform for Docetaxel-Degradation, Drug Delivery Study and Anticancer Activity.International journal of molecular sciences
  • Molecular PET Imaging Versus Conventional Imaging for Detection of Mandibular Metastases in Prostate Cancer: A Paired Retrospective Study.Cancers
  • ENO1 Is More Abundant than ENO2 on the Surface of Metastatic and Neuroendocrine Prostate Cancer Cells and Upregulated in High-Risk Prostate Tumors.International journal of molecular sciences
  • In Silico Dosimetric Comparison of Intensity-Modulated Photon Versus Proton Therapy for Pelvic and Para-Aortic Nodal Recurrence of Prostate Cancer Following Prior Irradiation.Cancers
  • PREDICT: a clinical tool to decide when to include the pelvis in prostate cancer radiotherapy. Development and multicohort external validation.Practical radiation oncology
  • Incidental Detection of PSMA-Avid Thymic Squamous Cell Carcinoma on [68Ga]Ga-PSMA-11 PET/CT During Initial Prostate Cancer Staging.Diagnostics (Basel, Switzerland)
  • Szisztematikus áttekintésAdverse event profiles of immune checkpoint inhibitor-based strategies for metastatic prostate cancer: a systematic review and network meta-analysis.Frontiers in medicine
  • PTEN Deletion, mTORC1 Signatures and CAD Expression in Primary Prostate Cancer: Protein-Level Data and the Role of ERG Fusion.Cells
  • Perioperative apalutamide plus ADT presents a new option for high-risk localized prostate cancer.Cancer
  • ÁttekintésStroma, Stress and Mitotic Control in Prostate Cancer: Evaluating Periostin, MAPK8IP2, CDCA3 and NCAPG2 Within an Evidence Gap Framework.Biology
  • CT-Defined Osteosarcopenia Is Associated with Mortality in Metastatic Prostate Cancer: A Longitudinal Analysis of Opportunistic CT Imaging.Journal of clinical medicine
  • Transient Receptor Potential Ankyrin 1 and Vanilloid 1 Receptor mRNAs Are Not Translated to Functional Ion Channels in Human Prostate Adenocarcinoma Cells.Cells
  • ÁttekintésACP3 Theranostics in Prostate Cancer.Cancers
  • ÁttekintésTranscriptional Reprogramming in Prostate Cancer: Altered AR Activity, the Modulatory Role of CDK8/19, and Prospects for Combination Therapy.International journal of molecular sciences
  • Baseline and early changes in neutrophil-lymphocyte ratio as a prognostic biomarker with 177Lu-PSMA-617 therapy in advanced prostate cancer.Prostate cancer and prostatic diseases
  • ÁttekintésPSA Dynamics, Bounce, and Biochemical Recurrence Definitions After Low-Dose-Rate Brachytherapy for Prostate Cancer: A Narrative Review with Cross-Modality Comparison.Diagnostics (Basel, Switzerland)
  • Spatial characterization of prostate cancer microenvironment with DRAQ5&Eosin fluorescence imaging and quantitative feature identification.Journal of pathology informatics
  • Pre-Diagnosis Metabolic Health-Related Dietary Index and Prostate Cancer-Specific Mortality.Nutrients
  • Comparison of biparametric and multiparametric MRI for detection of clinically significant prostate cancer using PI-RADS v2.1.Current problems in diagnostic radiology
  • Impact of a Reminder App on Bladder Filling During Moderately Hypo-Fractionated Radiotherapy for Prostate Cancer: Results of the REFILL-PAC-HYPO Trial.Journal of clinical medicine
  • Transcriptome-Informed Digital Twins Reveal a Functional Response Landscape in Prostate Cancer.International journal of molecular sciences
  • RIPK2 influences bone metastasis in prostate cancer through macrophage-tumor cell interaction: a mechanistic study.Minerva urology and nephrology
  • Anticancer potential of Amygdalus scoparia bee pollen extract against prostate (PC-3) cancer cell in vitro.Avicenna journal of phytomedicine
  • EsetismertetésIsolated testicular metastasis as a rare manifestation of castration-resistant prostate cancer.Urology case reports
  • Clinical Utility of Tumor-Detect Artificial Intelligence Algorithm for Detection of Prostate Cancer on Transurethral Resection Specimen.International journal of surgical pathology
  • The clinical and biological significance of TBRG4 expression in prostate cancer.Frontiers in oncology
  • Real-world lesion-level outcomes and toxicity after external beam radiation therapy for oligometastatic prostate cancer among patients receiving Lu-PSMA-617.Clinical and translational radiation oncology
  • ÁttekintésOligoprogressive Prostate Cancer: Can Metastasis-Directed Therapy Prolong the Benefit of Systemic Treatment?Clinical genitourinary cancer
  • Decisional conflict among patients with prostate cancer considering germline testing.Hereditary cancer in clinical practice
  • Patient and partner experiences of prostate cancer survivorship in Ireland: findings from the co-designed PRO-ACT study (CTRIAL-IE 24-45).World journal of urology
  • Predictors of first-attempt radiation treatment set up success in men with prostate cancer.Technical innovations & patient support in radiation oncology
  • Bioadhesive pH-responsive double-network hydrogel for local doxorubicin delivery against postoperative prostate cancer recurrence.Colloids and surfaces. B, Biointerfaces
  • Evaluating policy alternatives for population-based early detection programs for prostate cancer: organized screening, disorganized screening and restricted screening.Current opinion in urology
  • Szisztematikus áttekintésRisk-adapted active surveillance for prostate cancer: Can mpMRI, biomarkers, and genomic classifiers reduce biopsy burden without compromising safety?: A systematic review.Medicine
  • Slice-based YOLO-SAM hybrid prompting framework for automatic medical image segmentation.PloS one
  • Preclinical application of a dual-tracer SPECT approach with [111In]In-PSMA-I&T and [99mTc]Tc-DPD for improved diagnosis of prostate cancer.EJNMMI radiopharmacy and chemistry
  • ÁttekintésShared decision-making in the treatment of metastatic prostate cancer.Nature reviews. Urology